AGED Diagnostics Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 13

AGED Diagnostics General Information

Description

Operator of a biotechnology company intended to create a non-invasive test for liver disease. The company focuses on using transcriptional genetic analysis to identify the patterns of early tumorigenesis, enabling medical researchers to obtain an accurate depiction of their patients' health.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 6720A Rockledge Drive
  • Bethesda, MD 20817
  • United States
+1 (617)
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 6720A Rockledge Drive
  • Bethesda, MD 20817
  • United States
+1 (617)

AGED Diagnostics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AGED Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 20-Jul-2026 Completed Generating Revenue
7. Accelerator/Incubator 20-Oct-2025 Completed Generating Revenue
6. Later Stage VC 14-Aug-2025 Completed Generating Revenue
5. Accelerator/Incubator 23-Dec-2024 Completed Generating Revenue
4. Later Stage VC 28-Sep-2023 Completed Generating Revenue
3. Later Stage VC 01-Jan-2023 Completed Generating Revenue
2. Accelerator/Incubator 07-Dec-2021 $20K $30K Completed Generating Revenue
1. Accelerator/Incubator 08-Jul-2020 $10K $10K Completed Generating Revenue
To view AGED Diagnostics’s complete valuation and funding history, request access »

AGED Diagnostics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Convertible Pref
To view AGED Diagnostics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

AGED Diagnostics Patents

AGED Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4750919-A1 Systems and methods for methylation analysis of liver disease Pending 25-Jul-2023
WO-2025024670-A1 Systems and methods for methylation analysis of liver disease Inactive 25-Jul-2023
EP-4377480-A2 Methods and compositions for treating liver cancer and liver disease Inactive 30-Jul-2021
EP-4377480-A4 Methods and compositions for treating liver cancer and liver disease Inactive 30-Jul-2021
US-20250027164-A1 Methods and compositions for treating liver cancer and liver disease Pending 30-Jul-2021 C12Q1/6886
To view AGED Diagnostics’s complete patent history, request access »

AGED Diagnostics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AGED Diagnostics Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Plug and Play Accelerator/Incubator
Central Texas Angel Network Angel Group Minority
DMV Angel Group Angel Group Minority
Gloucester Ventures Venture Capital Minority
Intelligence Ventures Venture Capital Minority
You’re viewing 5 of 13 investors. Get the full list »

AGED Diagnostics FAQs

  • When was AGED Diagnostics founded?

    AGED Diagnostics was founded in 2018.

  • Where is AGED Diagnostics headquartered?

    AGED Diagnostics is headquartered in Bethesda, MD.

  • What is the size of AGED Diagnostics?

    AGED Diagnostics has 5 total employees.

  • What industry is AGED Diagnostics in?

    AGED Diagnostics’s primary industry is Laboratory Services (Healthcare).

  • Is AGED Diagnostics a private or public company?

    AGED Diagnostics is a Private company.

  • What is AGED Diagnostics’s current revenue?

    The current revenue for AGED Diagnostics is .

  • How much funding has AGED Diagnostics raised over time?

    AGED Diagnostics has raised $3.54M.

  • Who are AGED Diagnostics’s investors?

    Plug and Play, Central Texas Angel Network, DMV Angel Group, Gloucester Ventures, and Intelligence Ventures are 5 of 13 investors who have invested in AGED Diagnostics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process